AFMD
Affimed N.V.
NASDAQ · Healthcare · Biotechnology · DE
$0.18
+0.00%Latest reported
- Last report date
- Jun 11, 2025
- EPS actual
- -$1.38
- EPS estimate
- -$0.52
- Revenue actual
- —
- Revenue estimate
- $118.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -40.1%
- Revenue beats (12Q)
- 4
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2025